SCHEMBL1494414

SCHEMBL1494414

Cc1cc(Br)c(F)c(NC(=O)O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
RAB9A P51151 7/20 0.41
SMN1; SMN2 Q16637 5/20 0.41
NPC1 O15118 4/20 0.41
GPR35 Q9HC97 1/20 0.41
KMT2A Q03164 5/20 0.39
GAA P10253 2/20 0.39
LMNA P02545 2/20 0.37
MAPT P10636 5/20 0.37
TP53 P04637 1/20 0.37
THRB P10828 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 4/20 0.36
MYC P01106 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
HPGD P15428 3/20 0.36
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22232304 0.81 ALDH1A1 (0.44) ALDH1A1RAB9ASMN1; SMN2NPC1GPR35
SCHEMBL29177299 0.81 GPR35 (0.43) ALDH1A1RAB9ASMN1; SMN2GPR35KMT2A
SCHEMBL30699721 0.80 MAPK1 (0.48) ALDH1A1RAB9ASMN1; SMN2NPC1GPR35
SCHEMBL1494511 0.80 RAB9A (0.39) ALDH1A1RAB9ASMN1; SMN2NPC1GPR35
SCHEMBL6524156 0.79 LCK (0.40) ALDH1A1RAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL15408633 0.76 GPR35 (0.44) GPR35KMT2AMEN1
SCHEMBL22831837 0.75 TSHR (0.44) ALDH1A1RAB9ASMN1; SMN2KMT2ALMNA
SCHEMBL3226790 0.75 CA1 (0.32) ALDH1A1
SCHEMBL25314279 0.74 MAPT (0.39) ALDH1A1RAB9ASMN1; SMN2NPC1GPR35
SCHEMBL31038672 0.74 MAPT (0.39) ALDH1A1RAB9ASMN1; SMN2NPC1GPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2470528-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS Novartis AG (CH) 2012-07-04 EP disclosed
WO-2011023773-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS NOVARTIS AG (CH) 2011-03-03 WO disclosed